BNP Paribas Asset Management
CLB icon

BNP Paribas Asset Management’s Core Laboratories CLB Stock Holding History

BNP Paribas Asset Management’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$32.6K Sell
2,802
-13
-0.5% -$186 ﹤0.01% 1920
2026
Q1 		$47.3K Buy
2,815
+724
+35% +$13K ﹤0.01% 1767
2025
Q4 		$34K Sell
2,091
-406
-16% -$6.04K ﹤0.01% 1784
2025
Q3 		$31K Buy
2,497
+473
+23% +$5.54K ﹤0.01% 1218
2025
Q2 		$23K Buy
+2,024
New +$24K ﹤0.01% 1445
2017
Q3 		– Sell
-18,238
Closed -$1.85M – 938
2017
Q2 		$1.85M Buy
18,238
+1,327
+8% +$143K 0.02% 668
2017
Q1 		$1.95M Sell
16,911
-69
-0.4% -$8.02K 0.02% 659
2016
Q4 		$2.04M Sell
16,980
-7,811
-32% -$865K 0.02% 646
2016
Q3 		$2.79M Buy
24,791
+4,442
+22% +$512K 0.02% 638
2016
Q2 		$2.52M Buy
20,349
+247
+1% +$29.8K 0.02% 650
2016
Q1 		$2.26M Buy
20,102
+500
+3% +$51.9K 0.02% 657
2015
Q4 		$2.13M Buy
19,602
+3,648
+23% +$418K 0.02% 654
2015
Q3 		$1.59M Sell
15,954
-3,590
-18% -$390K 0.01% 734
2015
Q2 		$2.23M Sell
19,544
-1,136
-5% -$138K 0.02% 687
2015
Q1 		$2.16M Sell
20,680
-18,456
-47% -$1.97M 0.02% 696
2014
Q4 		$4.71M Sell
39,136
-36,135
-48% -$4.75M 0.04% 444
2014
Q3 		$11M Sell
75,271
-31,704
-30% -$4.89M 0.09% 262
2014
Q2 		$17.9M Buy
106,975
+64,828
+154% +$11.5M 0.14% 194
2014
Q1 		$8.36M Buy
42,147
+898
+2% +$169K 0.06% 313
2013
Q4 		$7.88M Buy
41,249
+5,205
+14% +$969K 0.06% 319
2013
Q3 		$6.1M Buy
36,044
+1,938
+6% +$301K 0.05% 341
2013
Q2 		$5.17M Buy
+34,106
New +$4.83M 0.04% 395

Other funds holding CLB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CAMG
CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $2.25B AUM 44.61% 1-Year Est. Return

BNP Paribas Asset Management's CLB Position: Q2 2026 in Review

BNP Paribas Asset Management reduced its Core Laboratories (CLB) stake by 0.46% in Q2 2026, selling an estimated $186 and leaving 2,802 shares worth $32.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1920.

BNP Paribas Asset Management first reported a position in CLB in Q2 2013 and has held it in 22 quarters since. The position peaked at $17.9M in Q2 2014. 148 funds tracked by Wall St. Rank hold CLB as of Q2 2026.

  • BNP Paribas Asset Management held 2,802 shares of Core Laboratories worth $32.6K as of Q2 2026.
  • BNP Paribas Asset Management sold 13 Core Laboratories shares in Q2 2026, an estimated $186.
  • Core Laboratories made up ﹤0.01% of BNP Paribas Asset Management's portfolio in Q2 2026, its #1920 holding.
  • BNP Paribas Asset Management first reported a position in Core Laboratories in Q2 2013 and has held it in 22 quarters since.
  • BNP Paribas Asset Management's Core Laboratories position peaked at $17.9M in Q2 2014.
  • 148 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2026.

Based on BNP Paribas Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.